Article Navigation

Back To Main Page


 

More Articles

The Risk of recurrence in prostate cancer


by: Fritz Frei

Prostate cancer disease

Prostate cancer - the most common form of cancer in men is Prostate cancer, the second leading cause of cancer death. The Main risk factors include age (incidence increases in men over the age of 65 years). It is more prevalent in the western world and about 10% of cases can be linked to family history. The recurrance Rate of the prostate cancer is high.

Mostly, the Prostate cancer is a continuum; progressing through localized, locally advanced, advanced and hormone-refractory stages In general it is a slow growing cancer. He is primarily under hormonal control i.e. testosterone. The choice of treatments which include watchful waiting, surgery (prostatectomy), radiotherapy, hormonal therapy and chemotherapy are dependent on the stage of disease.

1. Most important, that If detected early, using PSA determination, DRE examination and biopsies, and treated appropriately, survival rates are excellent.

2. The most critical focus for the treatment of prostate cancer is to treat those cancers where it is necessary.

3. The Decisions about the best management of prostate cancer can be very complex and depend upon the:

- Pathology of the cancer (unlike other cancers, prostate cancer often progresses very slowly)
- The impact that treatment can have on quality of life, including sexual activity
- Stage of the disease (non-metastatic (localized or locally advanced), metastatic or hormone refractory)
- Age and general health of the patients at diagnosis
- Patient’s preference for treatment
- PSA at diagnosis

4. The treatment options for prostate cancer are:

- Deferred treatment often called ‘watchful waiting’ or 'active surveillance'
- Surgery – Radical Prostatectomy
- Radiotherapy – External Beam and/or Brachytherapy
-Hormonal (endocrine) therapy – Androgen Ablation e.g. anti-androgens, medical castration (LHRHa) or surgical castration
- Chemotherapy
- Palliative Therapy e.g. chemotherapy
- Investigational Therapies

Prostate Cancer Recurrence Rates ***

Prostate cancer is now detected at earlier stages due to heightened awareness and improved screening techniques. Despite definitive therapy, cancer cells may remain and can go undetected for years until they develop into metastatic disease. The risk of recurrence is high, suggesting there is a need to improve treatment approaches. Therefore, it is important to predict pathological stage and risk of disease recurrence early, so that appropriate treatment and/or monitoring can be initiated. The result's of all new treatments will bring us in the future the chance of a lower prostate recurrance.

**You can inform you about the recurrence Rates on:
http://www.prostateline.com/prostatelinehcp/9898_15850_8_0_0.aspx

This gives you an overview with a study case – and the results.

Health-Service-Online
Admin Fritz

http://www.cancer-info.info




Latest Cancer News:



Pfizer to test Xalkori lung cancer drug with Merck immunotherapy


Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. Xalkori, which has annual sales of $400 million and is also known by its chemical name, crizotinib, was approved in 2011 for lung cancer patients who have a specific ... Global Cancer Diagnostics Announces Start of Final Validation Study for Its New Blood Test for the Early Detection of ...


Global Cancer Diagnostics Inc. today announced the start of the final validation study of its new blood test for early detection of lung cancer. The study will complete the requisite analyses and data evaluation needed to validate the test and introduce it to the market. Cancer Genetics' Proprietary Genomic Diagnostic Tests Added to National Institutes of Health's Genetic Testing Registry


RUTHERFORD, N.J. -- Cancer Genetics, Inc. ("CGI" or "The Company"), an emerging leader in DNA-based cancer diagnostics, announced today that the National Institutes of Health's (NIH) ... 10 questions to ask your doctor after a cancer diagnosis


Whether you have cancer or someone close to you does, there are some basic facts to understand about the diagnosis in order to begin moving forward with a treatment program New research details rare cancer that killed Bob Marley


Brooks Hays MANCHESTER, England, Aug. 20 (UPI) -- Acral melanomas -- a rare form of skin cancer and the type that claimed the life of reggae musician Bob Marley -- are genetically distinct. Ten Questions to Ask Your Doctor After a Cancer Diagnosis


Dr. Bavesh Balar is a board-certified hematologist and oncologist on staff at CentraState Medical Center in Freehold, N.J., where he serves as chairman of the Cancer Committee. The healthcare community has made remarkable strides over the past 20 years in treating cancer, but more than a million people in the United States are still diagnosed every year. As devastating as that news is, whether ... Pfizer to Test Lung Cancer Drug with Immunotherapy


Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in the hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. Exclusive: U.S. approval of Merck cancer immunotherapy expected soon


If approved by the Food and Drug Administration, the drug would be the first in a promising new class designed to help the body's own immune system fend off cancer by blocking a protein known as Programmed Death receptor (PD-1), or a related target known as PD-L1, used by tumors to evade disease-fighting cells. Companies including Bristol-Myers Squibb, Roche Holding AG and AstraZeneca Plc are ... Medicaid payouts for office visits may influence cancer screening: study


By Kathryn Doyle NEW YORK (Reuters Health) ? In states where Medicaid pays doctors higher fees for office visits, Medicaid beneficiaries are more likely to be screened for breast, cervical or colorectal cancer, according to a new study. ?States tend to vary in their reimbursement rates for different types of medical care services; Each state establishes its own coverage and reimbursement policies. NextGen Healthcare Earns 2014 ONC HIT Cancer Registry Certification


NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today NextGen® Ambulatory EHR version 5.8.1 is compliant with the ONC 2014 Edition criteria for certification measures 170.314 , Cancer Case Information, and 170.314 , Transmission to Cancer Registries ... NY1 anchor Roma Torre has colon cancer - New York Post


News Image
New York Daily News

News Image
NY1 anchor Roma Torre has colon cancer
New York Post
NY1 anchor Roma Torre broke the startling news to viewers on Tuesday that she's been diagnosed with colon cancer and has taken a leave of absence to be treated for the disease. ?When this happened, I was flummoxed,? Torre, 56, told The Post about ...
NY1 anchor Roma Torre diagnosed with colon cancerCapital New York
NY1 anchor Roma Torre to take leave after being diagnosed with colon cancerNew York Daily News
NY1's Roma Torre Diagnosed with Colon Cancer, Encourages Screening at Age ...NY1
mediabistro.com
all 8 news articles »
Tomatoes 'important in prostate cancer prevention' - BBC News


News Image
BBC News

News Image
Tomatoes 'important in prostate cancer prevention'
BBC News
Men who consume more than 10 portions of tomatoes each week reduce their risk by about 20%, according to a UK study. Prostate cancer is the second most common cancer in men worldwide, with 35,000 new cases and around 10,000 deaths in the UK ...
Tomatoes may reduce prostate cancer risk, study saysFox News
Tomato-rich diet can fight prostate cancerConsumerAffairs
Tomato-Rich Diet Linked To Lower Prostate Cancer RiskScience 2.0
BreakingNews.ie -Toronto Sun
all 25 news articles »
Healing Teenage Cancer's Scars - New York Times (blog)


News Image
New York Times (blog)

News Image
Healing Teenage Cancer's Scars
New York Times (blog)
When the prospects for treatment are uncertain, there's the fear of dying at so young an age. Even with an excellent chance of being cured, teenagers with cancer face myriad emotional, educational and social concerns, especially missing out on ...

2fm presenter Louise McSharry diagnosed with cancer - Irish Times


News Image
Irish Independent

News Image
2fm presenter Louise McSharry diagnosed with cancer
Irish Times
Her consultant told her ?pretty straight? that she had cancer. ?I was literally taken aback. I was physically moved back. I couldn't believe it. I had tears in my eyes immediately,? she said this morning. ?All I was thinking was, 'how am I going to ...
RTE radio presenter Louise McSharry has revealed she has been diagnosed ...Irish Independent
Louise McSharry on cancer diagnosis: 'They are brilliant odds'thejournal.ie
2FM host Louise 'feeling positive' as she reveals her cancer battleHerald.ie
Irish Mirror
all 10 news articles »
Diem Brown Opens Up About Fighting Cancer for a Third Time: I'm "Touched" by ... - Us Magazine


News Image
Us Magazine

News Image
Diem Brown Opens Up About Fighting Cancer for a Third Time: I'm "Touched" by ...
Us Magazine
Diem Brown is a fighter. Now battling cancer for a third time, the reality star is understandably scared, but nonetheless determined to beat the disease once and for all. Speaking exclusively with Us Weekly's Jennifer Peros about her recent diagnosis ...
Reality TV star Diem Brown battles cancer for 3rd timeFox News
Diem Brown battling cancer for third timeNew York Daily News
MTV Star Diem Brown Overwhelmed By Support As She Battles Cancer For The ...International Business Times AU
People Magazine -Daily Mail -E! Online
all 56 news articles »
'I've licked cancer, I may run for president' ? Santiago - Inquirer.net


News Image
Inquirer.net

News Image
'I've licked cancer, I may run for president' ? Santiago
Inquirer.net
MANILA, Philippines ? Just barely two months before announcing she had Stage 4 lung cancer, Senator Miriam Defensor-Santiago said she has now overcome it and is now considering running for president in 2016. ?I have licked cancer, and I'm actually ...
Miriam licks cancer, may run in 2016ABS CBN News
Miriam licks cancer, eyes running in 2016Philippine Star
Miriam says she has beaten cancer, may run for president in 2016InterAksyon

all 9 news articles »
For teens with cancer, challenges aren't simply medical - SFGate



News Image
For teens with cancer, challenges aren't simply medical
SFGate
The teenage years can be tough enough under the best of circumstances. But when cancer invades an adolescent's life, the challenges grow exponentially. When the prospects for treatment are uncertain, there's the fear of dying at so young an age. Even ...

and more »
Making Strides Against Breast Cancer campaign kicks off - Montgomery Advertiser


News Image
NBC Southern California

News Image
Making Strides Against Breast Cancer campaign kicks off
Montgomery Advertiser
There will be between 235,000 and 240,000 new cases of breast cancer in the United States this year ? and about 40,000 lives will be lost to the disease, said Stephen L. Davidson, a medical oncologist and hematologist as well as a partner at ...
Breakfast held as kickoff for "Making Strides Against Cancer" WalkWNDU-TV
Join NBC4 at Making Strides Against Breast Cancer WalkNBC Southern California

all 5 news articles »
Researchers identify breast cancer biomarker that could predict outcomes - Fox News


News Image
Fox News

News Image
Researchers identify breast cancer biomarker that could predict outcomes
Fox News
"We showed that elevated p66ShcA expression levels are strongly associated with expression of numerous epithelial to mesenchymal transition genes in all breast cancer subtypes," lead study author Josie Ursini-Siegel of McGill University said in a press ...
New biomarker highly promising for predicting breast cancer outcomesMedical Xpress

all 5 news articles »
UPDATED: Kite Pharma spikes on its second take of CAR-T cancer study - FierceBiotech


News Image
MarketWatch

News Image
UPDATED: Kite Pharma spikes on its second take of CAR-T cancer study
FierceBiotech
Kite Pharma has once again demonstrated just how hot experimental CAR-T technology is in the cancer field. The Santa Monica, CA-based biotech reported Monday evening in a trial update that 12 of 13 evaluable patients with advanced B cell malignancies ...
Kite Pharma's Cancer Drug Shows Positive Results in StudyWall Street Journal
Kite Pharma soars on promise of cancer treatmentUSA TODAY
CORRECTED-Kite Pharma's lead cancer therapy shows promise in studyReuters

all 50 news articles »

 



Home | Resource Links | Contact Us
Copyright © 2006 CancerAdvice.org